Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivity

American Journal of Cardiology

Volumn 115, Issue 6, 2015, Pages 716-723

  Lhermusier, Thibault ^a   Lipinski, Michael J ^a   Tantry, Udaya S ^b   Escarcega, Ricardo O ^a   Baker, Nevin ^a   Bliden, Kevin P ^b   Magalhaes, Marco A ^a   Ota, Hideaki ^a   Tian, Wenjie ^a   Pendyala, Lakshmana ^a   Minha, Saar ^a   Chen, Fang ^a   Torguson, Rebecca ^a   Gurbel, Paul A ^b   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PRASUGREL; TICAGRELOR; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANTICOAGULANT THERAPY; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; HUMAN; MAINTENANCE THERAPY; META ANALYSIS; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYSTEMATIC REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER;

EID: 84964194251     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.12.029     Document Type: Article

References (28)

1. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
2. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, M.K. Natarajan, K. Malmberg, H. Rupprecht, F. Zhao, S. Chrolavicius, I. Copland, K.A. Fox Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
3. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.-J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
4. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington PLATO Investigators A. Freij, and M. Thorsén Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
5. E.A. Amsterdam, N.K. Wenger, R.G. Brindis, D.E. Casey, T.G. Ganiats, D.R. Holmes, A.S. Jaffe, H. Jneid, R.F. Kelly, M.C. Kontos, G.N. Levine, P.R. Liebson, D. Mukherjee, E.D. Peterson, M.S. Sabatine, R.W. Smalling, and S.J. Zieman 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines Circulation 130 2014 2354 2394
6. G.W. Stone, B. Witzenbichler, G. Weisz, M.J. Rinaldi, F.-J. Neumann, D.C. Metzger, T.D. Henry, D.A. Cox, P.L. Duffy, E. Mazzaferri, P.A. Gurbel, K. Xu, H. Parise, A.J. Kirtane, B.R. Brodie, R. Mehran, T.D. Stuckey ADAPT-DES Investigators Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Lancet 382 2013 614 623
7. N.J. Breet, J.W. van Werkum, H.J. Bouman, J.C. Kelder, H.J.T. Ruven, E.T. Bal, V.H. Deneer, A.M. Harmsze, J.A.S. van der Heyden, B.J.W.M. Rensing, M.J. Suttorp, C.M. Hackeng, and J.M. ten Berg Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
8. L. Bonello, J. Mancini, M. Pansieri, L. Maillard, P. Rossi, F. Collet, B. Jouve, O. Wittenberg, M. Laine, P. Michelet, J. Bessereau, G. Lemesle, F. Dignat-George, F. Paganelli, and L. Camoin-Jau Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel J Thromb Haemost 10 2012 1999 2005
9. G. Campo, G. Parrinello, P. Ferraresi, B. Lunghi, M. Tebaldi, M. Miccoli, J. Marchesini, F. Bernardi, R. Ferrari, and M. Valgimigli Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome J Am Coll Cardiol 57 2011 2474 2483
10. D. Alexopoulos, I. Xanthopoulou, V. Gkizas, G. Kassimis, K.C. Theodoropoulos, G. Makris, N. Koutsogiannis, A. Damelou, G. Tsigkas, P. Davlouros, and G. Hahalis Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction Circ Cardiovasc Interv 5 2012 797 804
11. D. Alexopoulos, A. Galati, I. Xanthopoulou, E. Mavronasiou, G. Kassimis, K.C. Theodoropoulos, G. Makris, A. Damelou, G. Tsigkas, G. Hahalis, and P. Davlouros Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study J Am Coll Cardiol 60 2012 193 199
12. D. Alexopoulos, K. Stavrou, I. Koniari, V. Gkizas, A. Perperis, K. Kontoprias, C. Vogiatzi, T. Bampouri, and I. Xanthopoulou Ticagrelor vs prasugrel one-month maintenance therapy: impact on platelet reactivity and bleeding events Thromb Haemost 112 2014 551 557
13. D.J. Angiolillo, N. Curzen, P. Gurbel, P. Vaitkus, F. Lipkin, W. Li, J.A. Jakubowski, M. Zettler, M.B. Effron, and D. Trenk Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in subjects with stable coronary artery disease: results of the SWAP-2 study J Am Coll Cardiol 63 2014 1500 1509
14. P. Deharo, C. Bassez, G. Bonnet, M. Pankert, J. Quilici, M. Lambert, V. Verdier, P. Morange, M.-C. Alessi, J.-L. Bonnet, and T. Cuisset Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison Int J Cardiol 170 2013 e21 22
15. J.H. Lee, S.G. Ahn, J.-W. Lee, Y.J. Youn, M.-S. Ahn, J.-Y. Kim, B.-S. Yoo, S.-H. Lee, and J. Yoon Comparison of on-treatment platelet reactivity after one-month use of clopidogrel, prasugrel or ticagrelor in Koreans with acute coronary syndromes (TCT Asia Pacifica Oral Presentation) J Am Coll Cardiol 63 2014 S8
16. L. Perl, N. Zemer-Wassercug, E. Rechavia, M. Vaduganathan, K. Orvin, A. Weissler-Snir, H. Lerman-Shivek, R. Kornowski, and E.I. Lev Comparison of platelet inhibition by prasugrel versus ticagrelor over time in patients with acute myocardial infarction J Thromb Thrombolysis 39 2015 1 7
17. B. Aleil, L. Jacquemin, F. De Poli, M. Zaehringer, J.-P. Collet, G. Montalescot, J.-P. Cazenave, M.-C. Dickele, J.-P. Monassier, and C. Gachet Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study JACC Cardiovasc Interv 1 2008 631 638
18. D.J. Angiolillo, S.B. Shoemaker, B. Desai, H. Yuan, R.K. Charlton, E. Bernardo, M.M. Zenni, L.A. Guzman, T.A. Bass, and M.A. Costa Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study Circulation 115 2007 708 716
19. M.J. Price, P.B. Berger, P.S. Teirstein, J.-F. Tanguay, D.J. Angiolillo, D. Spriggs, S. Puri, M. Robbins, K.N. Garratt, O.F. Bertrand, M.E. Stillabower, M.E. Stillablower, J.R. Aragon, D.E. Kandzari, C.T. Stinis, M.S. Lee, S.V. Manoukian, C.P. Cannon, N.J. Schork, E.J. Topol GRAVITAS Investigators Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
20. P.A. Gurbel, K.P. Bliden, K. Butler, U.S. Tantry, T. Gesheff, C. Wei, R. Teng, M.J. Antonino, S.B. Patil, A. Karunakaran, D.J. Kereiakes, C. Parris, D. Purdy, V. Wilson, G.S. Ledley, and R.F. Storey Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease the ONSET/OFFSET study Circulation 120 2009 2577 2585
21. J.T. Brandt, C.D. Payne, S.D. Wiviott, G. Weerakkody, N.A. Farid, D.S. Small, J.A. Jakubowski, H. Naganuma, and K.J. Winters A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation Am Heart J 153 2007 66.e9 66.e16
22. S. Husted, H. Emanuelsson, S. Heptinstall, P.M. Sandset, M. Wickens, and G. Peters Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin Eur Heart J 27 2006 1038 1047
23. L. Bonello, M. Laine, N. Kipson, J. Mancini, O. Helal, J. Fromonot, V. Gariboldi, J. Condo, F. Thuny, C. Frere, L. Camoin-Jau, F. Paganelli, F. Dignat-George, and R. Guieu Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome J Am Coll Cardiol 63 2014 872 877
24. S. Dionisotti, S. Ferrara, C. Molta, C. Zocchi, and E. Ongini Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261 J Pharmacol Exp Ther 278 1996 1209 1214
25. M.D. Linden, M.R. Barnard, A.L. Frelinger, A.D. Michelson, and K. Przyklenk Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models Thromb Res 121 2008 689 698
26. M.T. Roe, P.W. Armstrong, K.A.A. Fox, H.D. White, D. Prabhakaran, S.G. Goodman, J.H. Cornel, D.L. Bhatt, P. Clemmensen, F. Martinez, D. Ardissino, J.C. Nicolau, W.E. Boden, P.A. Gurbel, W. Ruzyllo, A.J. Dalby, D.K. McGuire, J.L. Leiva-Pons, A. Parkhomenko, S. Gottlieb, G.O. Topacio, C. Hamm, G. Pavlides, A.R. Goudev, A. Oto, C.-D. Tseng, B. Merkely, V. Gasparovic, R. Corbalan, M. Cintezə, R.C. McLendon, K.J. Winters, E.B. Brown, Y. Lokhnygina, P.E. Aylward, K. Huber, J.S. Hochman, E.M. Ohman TRILOGY ACS Investigators Prasugrel versus clopidogrel for acute coronary syndromes without revascularization N Engl J Med 367 2012 1297 1309
27. U.S. Tantry, L. Bonello, D. Aradi, M.J. Price, Y.-H. Jeong, D.J. Angiolillo, G.W. Stone, N. Curzen, T. Geisler, J. Ten Berg, A. Kirtane, J. Siller-Matula, E. Mahla, R.C. Becker, D.L. Bhatt, R. Waksman, S.V. Rao, D. Alexopoulos, R. Marcucci, J.-L. Reny, D. Trenk, D. Sibbing, and P.A. Gurbel Consensus and update on the definition of on-treatment platelet reactivity to ADP associated with ischemia and bleeding J Am Coll Cardiol 62 2013 2261 2273
28. S. Schulz, D.J. Angiolillo, D. Antoniucci, I. Bernlochner, C. Hamm, J. Jaitner, K.-L. Laugwitz, K. Mayer, B. von Merzljak, T. Morath, F.-J. Neumann, G. Richardt, J. Ruf, G. Schömig, H. Schühlen, H. Schunkert, A. Kastrati Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial Investigators Randomized comparison of ticagrelor versus prasugrel in patients with acute coronary syndrome and planned invasive strategy - design and rationale of the iNtracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 trial J Cardiovasc Transl Res 7 2014 91 100